LEVACETYLLEUCINE

LEVACETYLLEUCINE was reported 251 times

LEVACETYLLEUCINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PROSTHETIC CARDIAC VALVE OBSTRUCTION 1 0.0833
1 MEDICAL DEVICE SITE THROMBOSIS 1 0.0097
2 OBSESSIVE-COMPULSIVE SYMPTOM 2 0.0054
3 COLD URTICARIA 1 0.0045
4 DIAPHRAGMATIC HERNIA 1 0.0016
5 BLOOD KETONE BODY INCREASED 1 0.0013
6 MEAN PLATELET VOLUME DECREASED 1 0.0012
7 ENTEROVIRUS INFECTION 1 0.0012
8 TRAUMATIC INTRACRANIAL HAEMORRHAGE 1 0.0011
9 PETIT MAL EPILEPSY 4 0.0008
10 RHINOVIRUS INFECTION 3 0.0008
11 CATAPLEXY 1 0.0007
12 SEIZURE LIKE PHENOMENA 1 0.0006
13 CELL DEATH 1 0.0005
14 MIDDLE EAR EFFUSION 1 0.0005
15 DROOLING 3 0.0004
16 PUSTULE 1 0.0004
17 WRONG DOSE 1 0.0004
18 CLUMSINESS 1 0.0004
19 RASH MORBILLIFORM 1 0.0004
20 RESPIRATORY RATE DECREASED 1 0.0003
21 PRODUCT PREPARATION ISSUE 2 0.0003
22 PNEUMONIA ASPIRATION 7 0.0003
23 TONGUE OEDEMA 1 0.0003
24 FAECES HARD 1 0.0003
25 HYPERPHAGIA 1 0.0003
26 MIOSIS 2 0.0002
27 PRODUCT PRESCRIBING ISSUE 5 0.0002
28 NYSTAGMUS 1 0.0002
29 GASTROINTESTINAL PAIN 2 0.0002
30 SOCIAL AVOIDANT BEHAVIOUR 1 0.0002
31 SKIN WARM 1 0.0002
32 TENSION 1 0.0002
33 RESPIRATORY DEPRESSION 2 0.0002
34 OFF LABEL USE 140 0.0002
35 COORDINATION ABNORMAL 2 0.0001
36 BRAIN FOG 2 0.0001
37 HEAD INJURY 4 0.0001
38 RHINITIS 1 0.0001
39 FRUSTRATION TOLERANCE DECREASED 1 0.0001
40 RESPIRATORY SYNCYTIAL VIRUS INFECTION 1 0.0001
41 SLEEP APNOEA SYNDROME 2 0.0001
42 SALIVARY HYPERSECRETION 1 0.0001
43 INITIAL INSOMNIA 1 0.0001
44 PRODUCT PREPARATION ERROR 2 0.0001
45 PETECHIAE 1 0.0001
46 SEIZURE 11 0.0001
47 TREATMENT NONCOMPLIANCE 5 0.0001
48 OBSTRUCTIVE AIRWAYS DISORDER 1 0.0001
49 EYE INFECTION 1 0.0001
50 MYOCARDITIS 1 0.0001
51 POST PROCEDURAL HAEMORRHAGE 1 0.0001
52 COGNITIVE DISORDER 4 0.0001
53 DYSPHAGIA 8 0.0001
54 BLOOD IRON DECREASED 1 0.0001
55 ATAXIA 1 0.0001
56 INTERSTITIAL LUNG DISEASE 4 0.0001
57 NOCTURIA 1 0.0001
58 RESTLESSNESS 3 0.0001
59 PLATELET COUNT INCREASED 1 0.0001
60 EAR INFECTION 2 0.0001
61 MOOD ALTERED 2 0.0001
62 HYPOMAGNESAEMIA 1 0.0001
63 HUNGER 1 0.0001
64 LYMPHOPENIA 1 0.0001
65 CARDIOGENIC SHOCK 1 0.0001
66 APATHY 1 0.0001
67 SWOLLEN TONGUE 2 0.0001
68 PHOTOSENSITIVITY REACTION 1 0.0001
69 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
70 SPEECH DISORDER 3 0.0001
71 EOSINOPHILIA 1 0.0001
72 SLEEP DISORDER 4 0.0001
73 THIRST 1 0.0001
74 OXYGEN SATURATION DECREASED 3 0.0001
75 DYSARTHRIA 2 0.0001
76 INTESTINAL OBSTRUCTION 2 0.0001
77 HYPOCALCAEMIA 1 0.0001
78 CHOLESTASIS 1 0.0001
79 HERNIA 1 0.0001
80 CHOKING 1 0.0001
81 ABNORMAL BEHAVIOUR 2 0.0001
82 POOR QUALITY SLEEP 1 0.0000
83 FAECES DISCOLOURED 1 0.0000
84 RASH MACULO-PAPULAR 1 0.0000
85 PRODUCT USE IN UNAPPROVED INDICATION 11 0.0000
86 PRODUCT PRESCRIBING ERROR 1 0.0000
87 PRODUCTIVE COUGH 2 0.0000
88 DIABETIC KETOACIDOSIS 1 0.0000
89 RESPIRATORY FAILURE 3 0.0000
90 UNRESPONSIVE TO STIMULI 1 0.0000
91 RESPIRATORY TRACT INFECTION 1 0.0000
92 DEAFNESS 1 0.0000
93 DISTURBANCE IN ATTENTION 2 0.0000
94 FREQUENT BOWEL MOVEMENTS 1 0.0000
95 GAIT DISTURBANCE 7 0.0000
96 MEMORY IMPAIRMENT 5 0.0000
97 RESPIRATORY ARREST 1 0.0000
98 MENTAL STATUS CHANGES 1 0.0000
99 FLATULENCE 2 0.0000
100 INTENTIONAL PRODUCT USE ISSUE 3 0.0000
101 IRRITABILITY 2 0.0000
102 FALL 11 0.0000
103 PRODUCT USE ISSUE 6 0.0000
104 LACTIC ACIDOSIS 1 0.0000
105 AMNESIA 2 0.0000
106 VIRAL INFECTION 1 0.0000
107 ANGER 1 0.0000
108 THERAPY INTERRUPTED 2 0.0000
109 HEPATIC FUNCTION ABNORMAL 1 0.0000
110 EPISTAXIS 2 0.0000
111 HALLUCINATION 2 0.0000
112 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
113 DECREASED APPETITE 6 0.0000
114 PNEUMONIA 8 0.0000
115 DEVICE DISLOCATION 1 0.0000
116 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
117 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
118 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
119 AGGRESSION 1 0.0000
120 CHEST DISCOMFORT 2 0.0000
121 VOMITING 9 0.0000
122 INSOMNIA 5 0.0000
123 INFLUENZA 2 0.0000
124 WEIGHT DECREASED 5 0.0000
125 LETHARGY 1 0.0000
126 DYSPHONIA 1 0.0000
127 DISEASE PROGRESSION 2 0.0000
128 HYPERSENSITIVITY 3 0.0000
129 RHINORRHOEA 1 0.0000
130 SWELLING FACE 1 0.0000
131 HEPATIC ENZYME INCREASED 1 0.0000
132 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
133 UNDERDOSE 1 0.0000
134 AGITATION 1 0.0000
135 ACNE 1 0.0000
136 THROMBOSIS 1 0.0000
137 TREMOR 2 0.0000
138 URINARY TRACT INFECTION 2 0.0000
139 INTENTIONAL PRODUCT MISUSE 1 0.0000
140 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2 0.0000
141 SOMNOLENCE 2 0.0000
142 FLUSHING 1 0.0000
143 SINUSITIS 1 0.0000
144 ERYTHEMA 2 0.0000
145 HAEMORRHAGE 1 0.0000
146 DIARRHOEA 6 0.0000
147 CONSTIPATION 2 0.0000
148 MUSCULAR WEAKNESS 1 0.0000
149 INCORRECT DOSE ADMINISTERED 2 0.0000
150 LOSS OF CONSCIOUSNESS 1 0.0000
151 HYPERHIDROSIS 1 0.0000
152 HYPOAESTHESIA 1 0.0000
153 PARAESTHESIA 1 0.0000
154 CONFUSIONAL STATE 1 0.0000
155 URTICARIA 1 0.0000
156 ABDOMINAL DISCOMFORT 1 0.0000
157 TOXICITY TO VARIOUS AGENTS 1 0.0000
158 DEATH 5 0.0000
159 NAUSEA 4 0.0000
160 OVERDOSE 1 0.0000
161 RASH 2 0.0000
162 WEIGHT INCREASED 1 0.0000
163 DEPRESSION 1 0.0000
164 ABDOMINAL PAIN 1 0.0000
165 FEELING ABNORMAL 1 0.0000
166 FATIGUE 3 0.0000
167 DRUG INEFFECTIVE 5 0.0000
168 PRODUCT DOSE OMISSION ISSUE 1 0.0000
169 CONDITION AGGRAVATED 1 0.0000
170 PRURITUS 1 0.0000
171 MALAISE 1 0.0000
172 DYSPNOEA 1 0.0000